ANGO

Angiodynamics Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth 8/10
  • Value 1/10
Angiodynamics sales and earnings growth
ANGO Growth
Good
  • Revenue Y/Y 8.71%
  • EPS Y/Y 25.74%
  • FCF Y/Y 91.56%
Angiodynamics gross and profit margin trends
ANGO Profitability
Neutral
  • Gross margin 54.30%
  • EPS margin -10.00%
  • ROIC 5Y -101.57%
Angiodynamics net debt vs free cash flow
ANGO Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -41.0

Angiodynamics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Medical Instruments & Supplies stocks